Free Trial

BioVie (BIVI) Competitors

BioVie logo
$6.67 -0.30 (-4.36%)
Closing price 03:58 PM Eastern
Extended Trading
$6.85 +0.18 (+2.76%)
As of 04:15 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

BIVI vs. APLT, RPTX, CRVO, ASRT, STRO, HOWL, SCLX, IKNA, BRNS, and MNOV

Should you be buying BioVie stock or one of its competitors? The main competitors of BioVie include Applied Therapeutics (APLT), Repare Therapeutics (RPTX), CervoMed (CRVO), Assertio (ASRT), Sutro Biopharma (STRO), Werewolf Therapeutics (HOWL), Scilex (SCLX), Ikena Oncology (IKNA), Barinthus Biotherapeutics (BRNS), and MediciNova (MNOV). These companies are all part of the "pharmaceutical products" industry.

BioVie vs. Its Competitors

Applied Therapeutics (NASDAQ:APLT) and BioVie (NASDAQ:BIVI) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, risk, analyst recommendations, earnings, valuation, profitability, media sentiment and dividends.

In the previous week, Applied Therapeutics and Applied Therapeutics both had 5 articles in the media. Applied Therapeutics' average media sentiment score of 0.79 beat BioVie's score of 0.61 indicating that Applied Therapeutics is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Applied Therapeutics
1 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
BioVie
1 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

98.3% of Applied Therapeutics shares are owned by institutional investors. Comparatively, 4.6% of BioVie shares are owned by institutional investors. 1.6% of Applied Therapeutics shares are owned by insiders. Comparatively, 2.4% of BioVie shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

BioVie's return on equity of -100.88% beat Applied Therapeutics' return on equity.

Company Net Margins Return on Equity Return on Assets
Applied TherapeuticsN/A -184.67% -84.02%
BioVie N/A -100.88%-78.49%

Applied Therapeutics has a beta of 1.82, meaning that its stock price is 82% more volatile than the S&P 500. Comparatively, BioVie has a beta of 0.73, meaning that its stock price is 27% less volatile than the S&P 500.

BioVie has lower revenue, but higher earnings than Applied Therapeutics. Applied Therapeutics is trading at a lower price-to-earnings ratio than BioVie, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Applied Therapeutics$460K132.96-$105.62M-$0.43-1.00
BioVieN/AN/A-$32.12M-$79.10-0.08

Applied Therapeutics presently has a consensus price target of $6.10, indicating a potential upside of 1,312.04%. Given Applied Therapeutics' higher possible upside, analysts plainly believe Applied Therapeutics is more favorable than BioVie.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Applied Therapeutics
0 Sell rating(s)
3 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.50
BioVie
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
1 Strong Buy rating(s)
4.00

Summary

Applied Therapeutics and BioVie tied by winning 7 of the 14 factors compared between the two stocks.

Get BioVie News Delivered to You Automatically

Sign up to receive the latest news and ratings for BIVI and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BIVI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BIVI vs. The Competition

MetricBioVieMED IndustryMedical SectorNASDAQ Exchange
Market Cap$12.40M$2.46B$5.59B$9.53B
Dividend YieldN/A1.77%4.71%4.03%
P/E Ratio-0.089.4927.9619.93
Price / SalesN/A427.91389.5465.88
Price / CashN/A165.5736.3258.75
Price / Book0.264.968.375.77
Net Income-$32.12M$31.62M$3.25B$259.10M
7 Day Performance-19.10%-3.27%-2.50%-3.41%
1 Month Performance-27.94%9.78%7.98%8.53%
1 Year Performance73.55%-5.75%34.65%15.75%

BioVie Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BIVI
BioVie
0.91 of 5 stars
$6.67
-4.4%
N/A+70.0%$12.40MN/A-0.0810
APLT
Applied Therapeutics
4.2934 of 5 stars
$0.46
-0.4%
$6.10
+1,226.1%
-91.2%$65.39M$460K-1.0730News Coverage
Upcoming Earnings
RPTX
Repare Therapeutics
2.8084 of 5 stars
$1.50
-0.7%
$4.50
+200.0%
-61.7%$64.77M$53.48M-0.50180Upcoming Earnings
CRVO
CervoMed
3.2249 of 5 stars
$8.43
+13.8%
$22.57
+167.8%
-41.6%$64.49M$9.74M-3.874News Coverage
Analyst Forecast
Gap Up
ASRT
Assertio
2.1247 of 5 stars
$0.70
+3.3%
$2.75
+295.7%
-51.3%$64.46M$124.96M-2.1720News Coverage
Positive News
Upcoming Earnings
STRO
Sutro Biopharma
4.2165 of 5 stars
$0.80
+5.3%
$6.11
+664.3%
-80.4%$64.19M$62.04M-0.27240
HOWL
Werewolf Therapeutics
4.0182 of 5 stars
$1.40
-0.7%
$8.33
+495.2%
-51.5%$63.27M$1.88M-0.8440News Coverage
SCLX
Scilex
2.5276 of 5 stars
$8.60
-2.9%
$455.00
+5,190.7%
-71.7%$61.59M$56.59M-0.3080
IKNA
Ikena Oncology
N/A$1.27
flat
$3.00
+136.2%
N/A$61.29M$9.16M-1.4870Earnings Report
Stock Split
High Trading Volume
BRNS
Barinthus Biotherapeutics
3.4714 of 5 stars
$1.97
+31.5%
$6.25
+217.3%
+3.4%$60.41M$14.97M-1.20107Positive News
Upcoming Earnings
High Trading Volume
MNOV
MediciNova
1.6011 of 5 stars
$1.26
+2.4%
$7.00
+455.6%
+2.3%$60.33M$1M-5.4810Upcoming Earnings

Related Companies and Tools


This page (NASDAQ:BIVI) was last updated on 7/30/2025 by MarketBeat.com Staff
From Our Partners